These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11453955)

  • 1. GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related serum markers, resting heart rate and resting oxygen uptake.
    Lange KH; Isaksson F; Rasmussen MH; Juul A; Bülow J; Kjaer M
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):77-86. PubMed ID: 11453955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum leptin response to the acute and chronic administration of growth hormone (GH) to elderly subjects with GH deficiency.
    Gill MS; Toogood AA; Jones J; Clayton PE; Shalet SM
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1288-95. PubMed ID: 10199769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
    Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
    Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
    Blackman MR; Sorkin JD; Münzer T; Bellantoni MF; Busby-Whitehead J; Stevens TE; Jayme J; O'Connor KG; Christmas C; Tobin JD; Stewart KJ; Cottrell E; St Clair C; Pabst KM; Harman SM
    JAMA; 2002 Nov; 288(18):2282-92. PubMed ID: 12425705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
    Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependent changes in body composition in postmenopausal Japanese women: relationship to growth hormone secretion as well as serum levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Sugimoto T; Nakaoka D; Nasu M; Kanzawa M; Sugishita T; Chihara K
    Eur J Endocrinol; 1998 Jun; 138(6):633-9. PubMed ID: 9678529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women.
    Tagliaferri M; Scacchi M; Pincelli AI; Berselli ME; Silvestri P; Montesano A; Ortolani S; Dubini A; Cavagnini F
    Int J Obes Relat Metab Disord; 1998 Sep; 22(9):836-41. PubMed ID: 9756240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor I (IGF-I) replacement during growth hormone receptor antagonism normalizes serum IGF-binding protein-3 and markers of bone formation in ovariectomized rhesus monkeys.
    Wilson ME
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1557-62. PubMed ID: 10770197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone enhances effects of endurance training on oxidative muscle metabolism in elderly women.
    Lange KH; Isaksson F; Juul A; Rasmussen MH; Bülow J; Kjaer M
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E989-96. PubMed ID: 11052952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.
    Vittone J; Blackman MR; Busby-Whitehead J; Tsiao C; Stewart KJ; Tobin J; Stevens T; Bellantoni MF; Rogers MA; Baumann G; Roth J; Harman SM; Spencer RG
    Metabolism; 1997 Jan; 46(1):89-96. PubMed ID: 9005976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.
    Sääf M; Hilding A; Thorën M; Troell S; Hall K
    Eur J Endocrinol; 1999 May; 140(5):390-9. PubMed ID: 10229902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
    Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters.
    Møller J; Jørgensen JO; Lauersen T; Frystyk J; Naeraa RW; Orskov H; Christiansen JS
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):403-8. PubMed ID: 7507009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis.
    Sugimoto T; Kaji H; Nakaoka D; Yamauchi M; Yano S; Sugishita T; Baylink DJ; Mohan S; Chihara K
    Eur J Endocrinol; 2002 Sep; 147(3):339-48. PubMed ID: 12213671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in serum growth hormone (GH)/GH dependent ternary complex components (IGF-I, IGFBP-3, ALS, IGF-I/IGFBP-3 molar ratio) and the influence of these alterations on growth pattern in female rhythmic gymnasts.
    Adiyaman P; Ocal G; Berberoğlu M; Evliyaoğlu O; Aycan Z; Cetinkaya E; Bulca Y; Ersöz G; Akar N
    J Pediatr Endocrinol Metab; 2004 Jun; 17(6):895-903. PubMed ID: 15270408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.